SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $84,000 | -66.5% | 1,073 | -61.6% | 0.11% | -60.4% |
Q4 2021 | $251,000 | +100.8% | 2,792 | +73.8% | 0.28% | +105.0% |
Q2 2021 | $125,000 | -65.2% | 1,606 | -66.7% | 0.14% | -69.3% |
Q1 2021 | $359,000 | +1531.8% | 4,817 | +3663.3% | 0.45% | +1462.1% |
Q4 2020 | $22,000 | +2100.0% | 128 | +1728.6% | 0.03% | +1350.0% |
Q3 2020 | $1,000 | – | 7 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |